Span Divergent Limited

BSE: SDL524727ISIN INE004E01016

Healthcare
Pharmaceuticals

Share price

₹24.50+0.56 (+2.34%)

as of 30 Oct 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹51.49
52W low: ₹20.52
Off 52W high: -52.42%
1M return: +1.45%
3M return: -23.00%
6M return: -33.19%
1Y return: -3.39%
20D avg volume: 1,095
50 DMA: ₹27.11
200 DMA: ₹28.08

Key ratios Consolidated

Market cap: ₹17.79 Cr
Current price: ₹24.50
52W high / low: ₹51.49 / ₹20.52
Face value: ₹10.00
P/E: -4.90
P/B: 1.20
EPS (TTM): ₹-5.00
Book value / share: ₹20.46
ROE: —
ROCE: -21.50%
Operating margin: —
Net margin: —
Debt / equity: 0.73
Net debt: ₹0.66 Cr
Interest cover: -5.74
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: -54.1 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	1.02	4.64	3.87	7.64	1.07	0.55	1.90	2.81	3.71	—
	0.28	0.15	0.20	0.22	0.72	0.34	0.43	0.25	0.17	—
	1.30	4.79	4.07	7.86	1.79	0.88	2.33	3.05	3.88	—
	2.45	5.92	5.34	8.03	2.13	1.87	2.54	3.00	3.88	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	4.78	4.39	1.22	6.46	4.24	0.31	1.40	0.17	0.93	—
	0.47	0.56	0.53	0.54	0.51	0.60	0.56	0.62	0.53	—
	0.14	0.12	0.11	0.12	0.12	0.15	0.14	0.15	0.16	—
	0.24	0.30	0.28	0.27	0.27	0.24	0.28	0.28	0.28	—
	0.84	0.41	0.49	0.68	0.53	0.49	0.64	1.68	1.53	—
	-1.15	-1.13	-1.27	-0.17	-0.34	-0.99	-0.21	0.06	0.00	—
	0.00	0.00	0.14	0.00	0.19	0.00	0.04	0.00	0.02	—
	-1.15	-1.13	-1.13	-0.16	-0.14	-0.99	-0.17	0.06	0.02	—
	0.04	-0.01	0.01	0.02	0.03	0.04	0.04	0.01	0.11	—
	-1.19	-1.12	-1.14	-0.19	-0.17	-1.02	-0.21	0.05	-0.09	—
	-1.64	-2.02	-2.08	-0.34	-0.31	-1.87	-0.39	0.09	-0.16	—
Key metrics
	-0.77	-0.71	-0.74	0.23	0.25	-0.60	0.25	0.49	0.46	—
	-75.50%	-15.30%	-19.10%	3.00%	23.40%	-109.10%	13.20%	17.40%	12.40%	—
	-116.70%	-24.10%	-29.50%	-2.50%	-15.90%	-185.50%	-11.10%	1.80%	-2.40%	—
	—	-8.80%	—	0.70%	—	17.90%	—	—	—	—
	-4.70%	743.60%	103.70%	171.90%	-71.20%	—	—	—	—	—
	-600.00%	-9.80%	-442.90%	-480.00%	-88.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	17.17	17.23	8.96	—
	0.85	1.29	1.19	—
	18.02	18.51	10.15	—
	21.74	21.42	11.29	—
	0.00	0.00	0.00	—
	16.85	16.30	2.80	—
	2.10	2.15	2.31	—
	0.49	0.43	0.60	—
	1.09	1.17	1.09	—
	2.42	2.09	4.33	—
	-3.72	-2.90	-1.14	—
	0.14	0.00	0.06	—
	-3.57	-2.90	-1.08	—
	0.06	0.04	0.19	—
	-3.64	-2.95	-1.27	—
	-6.08	-5.38	-2.33	—
Key metrics
	-1.99	-1.30	0.61	—
	-11.59%	-7.50%	6.80%	—
	-21.20%	-17.10%	-14.20%	—
	—	-21.50%	10.20%	—
	171.25%	92.30%	—	—
	—	-132.30%	—	—
	—	-0.19	1.86	—
	—	-0.07	-1.46	—
	—	0.73	-0.94	—
	—	0.66	7.76	—
	—	-54.1	-43.6	—
Balance sheet
	—	28.90	23.20	—
	—	19.12	12.38	—
	—	6.48	0.59	—
	—	1.54	1.39	—
	—	1.72	1.00	—
	—	3.21	2.23	—
	—	9.31	9.63	—
	—	5.81	3.46	—
	—	17.41	27.89	—
	—	7.14	8.35	—
	—	7.05	5.76	—
	—	0.09	2.59	—
	—	9.83	-8.84	—
Cash flow
	—	0.22	1.86	—
	—	1.55	-1.05	—
	—	4.12	-1.15	—
	—	0.41	0.00	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.14	0.36	0.36	0.37	0.39	0.32	0.34	0.43	0.51	—
	0.17	0.12	0.18	0.19	0.27	0.36	0.30	0.26	0.22	—
	0.31	0.48	0.54	0.56	0.65	0.68	0.64	0.70	0.73	—
	0.47	0.52	0.53	0.45	0.41	0.54	0.42	0.45	0.42	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.26	0.36	0.29	0.30	0.27	0.35	0.28	0.29	0.26	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.06	0.07	0.07	0.06	0.06	0.06	0.06	0.06	0.06	—
	0.14	0.09	0.18	0.08	0.08	0.12	0.08	0.09	0.09	—
	-0.16	-0.04	0.01	0.11	0.24	0.14	0.22	0.25	0.31	—
	0.13	0.08	0.14	0.00	0.19	0.00	0.04	—	0.02	—
	-0.03	0.04	0.15	0.12	0.43	0.14	0.26	0.25	0.33	—
	0.02	-0.02	0.01	-0.01	0.01	0.01	0.02	0.01	0.10	—
	-0.04	0.05	0.14	0.12	0.42	0.13	0.23	0.24	0.23	—
	-0.06	0.09	0.25	0.22	0.76	0.24	0.43	0.44	0.42	—
Key metrics
	0.03	0.11	0.22	0.18	0.49	0.20	0.32	0.31	0.39	—
	21.40%	30.60%	61.10%	48.60%	125.60%	62.50%	94.10%	72.10%	76.50%	—
	-28.60%	13.90%	38.90%	32.40%	107.70%	40.60%	67.60%	55.80%	45.10%	—
	—	0.10%	—	0.30%	—	0.40%	—	—	—	—
	-64.10%	12.50%	5.90%	-14.00%	-23.50%	—	—	—	—	—
	-109.50%	-61.50%	-39.10%	-50.00%	82.60%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1.23	1.47	1.61	—
	0.66	0.76	1.15	—
	1.89	2.22	2.76	—
	1.97	1.91	1.84	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	1.21	1.23	1.20	—
	0.00	0.02	0.00	—
	0.26	0.26	0.25	—
	0.49	0.40	0.39	—
	-0.08	0.32	0.92	—
	0.35	0.41	0.06	—
	0.28	0.73	0.98	—
	0.00	0.00	0.14	—
	0.27	0.73	0.84	—
	0.50	1.33	1.54	—
Key metrics
	0.54	1.01	1.23	—
	43.90%	68.70%	76.40%	—
	21.95%	49.70%	52.20%	—
	—	1.80%	2.60%	—
	-16.89%	-8.70%	—	—
	-73.53%	-13.10%	—	—
	—	0.00	0.70	—
	—	0.08	1.19	—
	—	0.05	0.06	—
	—	-3.72	1.81	—
	—	49.6	63.5	—
Balance sheet
	—	46.57	39.96	—
	—	11.11	6.82	—
	—	5.85	0.42	—
	—	0.28	0.33	—
	—	0.00	0.00	—
	—	0.01	0.01	—
	—	3.15	3.37	—
	—	0.08	0.05	—
	—	4.29	2.15	—
	—	2.13	2.23	—
	—	2.04	0.12	—
	—	0.09	2.11	—
	—	41.22	34.75	—
Cash flow
	—	0.06	1.00	—
	—	-0.21	-1.10	—
	—	5.58	0.15	—
	—	0.06	0.30	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -16.89%
Profit YoY (TTM): -73.53%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +171.25%
Profit YoY (TTM): -169.63%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 48.13%

Quarter	September 2026	June 2026
Promoter %	48.13%	48.13%

Holder	Type	Holding	Previous	Change
PRADIPKUMAR KESHAVLAL DESAI	Promoter	32.16%	32.16%	0.00%
NEEV NIRAV JOGANI	Public	24.80%	24.80%	0.00%
VIRAL PRADIPKUMAR DESAI	Promoter	9.47%	9.47%	0.00%
BHARTIBEN NATWERLAL PATEL	Public	7.92%	7.92%	0.00%
GITA SURESHBHAI DESAI	Promoter Group	1.58%	1.58%	0.00%
Investor Education and Protection Fund (IEPF)	Public	1.55%	1.55%	0.00%
SANJAY N MEHTA HUF	Public	1.51%	1.51%	0.00%
SUJATA V DESAI	Promoter Group	1.40%	1.40%	0.00%
LUXMI KANT GUPTA	Public	1.28%	1.26%	+0.02%
UDAYBHAI DHIRUBHAI DESAI	Promoter Group	1.23%	1.23%	0.00%
SURESH D DESAI	Promoter Group	0.46%	0.46%	0.00%
UDAYBHAI DHIRUBHAI DESAI HUF	Promoter Group	0.41%	0.41%	0.00%
TEJAL VIVEK DESAI	Promoter Group	0.41%	0.41%	0.00%
PRANAV S DESAI	Promoter Group	0.39%	0.39%	0.00%
PRASHANT SURESH DESAI	Promoter Group	0.36%	0.36%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,652	1,778.25	38.83	17.90%	+12.13% TTM	+4.79% TTM	+4.38%
Divi's Laboratories Ltd.	2,57,903	9,715.00	88.17	19.00%	+16.35% TTM	+26.84% TTM	+46.01%
Torrent Pharmaceuticals Ltd.	1,76,300	4,635.15	84.00	9.10%	+42.06% TTM	-1.92% TTM	+28.72%
Laurus Labs Limited	1,29,243	2,392.00	97.01	19.70%	+23.03% TTM	+95.38% TTM	+146.60%
Zydus Lifesciences Limited	1,24,089	1,244.00	27.02	19.20%	+21.11% TTM	-2.51% TTM	+26.13%
Dr. Reddy's Laboratories Ltd.	1,12,693	1,350.20	40.84	13.90%	-3.53% TTM	-51.90% TTM	+12.32%
Cipla Ltd.	1,11,486	1,380.00	39.07	14.90%	-0.74% TTM	-47.48% TTM	-10.42%
Mankind Pharma Limited	1,02,797	2,488.75	45.41	13.70%	+13.27% TTM	+27.60% TTM	+1.76%
Aurobindo Pharma Ltd.	96,537	1,677.80	26.02	13.60%	+9.09% TTM	+9.48% TTM	+52.18%
Lupin Ltd	91,870	2,009.00	16.55	28.40%	+28.19% TTM	+49.13% TTM	+3.29%
Glenmark Pharmaceuticals ltd	65,137	2,308.00	36.23	16.20%	+32.94% TTM	+138.48% TTM	+22.53%
Alkem Laboratories Limited	61,277	5,125.00	27.80	18.80%	+13.36% TTM	-5.52% TTM	-7.22%
Biocon Ltd.	57,365	352.00	137.76	2.90%	+9.83% TTM	-36.60% TTM	-6.63%
Abbott India Ltd. S	54,384	25,593.30	33.68	41.90%	+6.29% TTM	+11.18% TTM	-13.64%
Gland Pharma Limited	51,112	3,097.50	45.28	13.70%	+17.57% TTM	+46.55% TTM	+61.94%
Ipca Laboratories Ltd.	48,898	1,927.70	35.56	16.40%	+10.59% TTM	+67.91% TTM	+49.58%
Ajanta Pharma Ltd.	43,891	3,512.40	34.76	29.40%	+25.01% TTM	+29.70% TTM	+42.26%
GlaxoSmithkline Pharmaceuticals Ltd.	42,073	2,483.55	39.39	55.40%	+5.75% TTM	+12.41% TTM	-5.19%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Emcure Pharmaceuticals Limited	35,440	1,868.10	34.78	25.10%	+18.36% TTM	+32.39% TTM	+39.92%
Sai Life Sciences Limited	33,139	1,559.70	91.59	18.10%	—	—	+69.37%
ACUTAAS CHEMICALS LIMITED	32,770	4,002.65	74.71	27.70%	+45.18% TTM	+95.78% TTM	+134.62%
PIRAMAL PHARMA LIMITED	31,826	239.05	-152.01	0.80%	+9.43% TTM	-781.93% TTM	+18.40%
Wockhardt Ltd	30,809	1,896.10	74.42	6.40%	+18.37% TTM	+377.85% TTM	+46.86%
RUBICON RESEARCH LIMITED	26,650	1,609.90	92.46	24.30%	—	—	+164.22%
Span Divergent Limited	18	24.50	-4.90	-21.50%	+171.25% TTM	-169.63% TTM	-3.39%

Filings & corporate actions

Recent announcements

Span Divergent Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. To consider and approve ....30 Oct 2026 · Board Meeting / Board Meeting
Span Divergent Limited- Certificate under Regulation 74(5) of SEBI (DP) Regulations, 20189 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Span Divergent Limited-E-voting result and Scrutinizer''s Report for the 46th Annual General Meeting held on Monday, September 28, 202629 Sep 2026 · AGM/EGM / AGM
Span Divergent Limited-Summary of Proceedings of the Annual General Meeting held on September 28, 202628 Sep 2026 · AGM/EGM / AGM
Span Divergent Limited-Intimation for closure of trading window21 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Span Divergent Limited-Newspaper publication related to 46th Annual General Meeting, e-voting and other related information3 Sep 2026 · Company Update / Newspaper Publication
Span Divergent Limited-Notice of the 46th Annual General Meeting of the company scheduled to be held on Monday, September 28, 20262 Sep 2026 · AGM/EGM / AGM
Span Divergent Limited_Integrated Annual Report for the Financial Year 2025-2026 along with Notice of 46th Annual General Meeting2 Sep 2026 · Others / Reg. 34 (1) Annual Report
Span Divergent Limited-Newspaper publication pertaining to 46th Annual General Meeting of the company26 Aug 2026 · Company Update / Newspaper Publication
Span Divergent Limited-Announcement under Regulation 30 (LODR)-Newspaper Publication12 Aug 2026 · Company Update / Newspaper Publication
Span Divergent Limited-Financial Results for the quarter end June 30, 202611 Aug 2026 · Result / Financial Results
Span Divergent Limited Outcome of Board Meeting held on August 11, 202611 Aug 2026 · Board Meeting / Outcome of Board Meeting
Span Divergent Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. The un audited Standalone ....5 Aug 2026 · Board Meeting / Board Meeting
Span Divergent Limited_Compliances -Certificate under Regulation 74(5) of SEBI (DP) Regulations, 201813 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 (LODR) Intimation of receipt of Arbitration Award6 Jul 2026 · Company Update / Award of Order / Receipt of Order
Span Divergent Limited - Intimation of Insider Trading Window Closure24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Span Divergent Limited - Announcement under Regulation 30 (LODR) - Newspaper Publication1 Jun 2026 · Company Update / Newspaper Publication
Span Divergent Limited - Intimation for Re-appointment of Internal Auditor of the Company30 May 2026 · Company Update / General
Span Divergent Limited - Intimation of Book Closure30 May 2026 · Corp. Action / Book Closure
Span Divergent Limited - Audited Standalone and Consolidated Results for March 31, 202630 May 2026 · Result / Financial Results
Span Divergent Limited - Outcome of Board Meeting held on May 30, 202630 May 2026 · Board Meeting / Outcome of Board Meeting
Span Divergent Limited - Annual Secretarial Compliance for the year ended on March 31, 202630 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Span Divergent Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. To consider and approve ....25 May 2026 · Board Meeting / Board Meeting
Span Divergent Limited - Intimation of Change in Name of Subsidiary LLP pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 201522 May 2026 · Company Update / General
Span Divergent Limited - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 in relation to ....14 May 2026 · Company Update / General
Span Divergent Limited - Intimation for Receipt of Listing Approval6 May 2026 · Company Update / General
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....17 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....17 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Span Divergent Limited - Certificate under Reg 74(5) of SEBI (DP) Regulation, 20189 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neev Nirav Jogani2 Apr 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neev Nirav Jogani2 Apr 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Span Divergent Limited - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to ....28 Mar 2026 · Company Update / Preferential Issue
Span Divergent Limited - Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 in relation to the allotment ....28 Mar 2026 · Company Update / Allotment of Equity Shares
Span Divergent Limited - Outcome of Board Meeting held on March 28, 202628 Mar 2026 · Others / Outcome without intimation
Span Divergent Limited - Intimation of Closure of Trading Window25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Span Divergent Limited - Intimation of Receipt of In-principle approval from BSE Limited for Preferential Issue of Equity Shares20 Mar 2026 · Company Update / Preferential Issue
Span Divergent Limited-Announcement under Regulation 30 (LODR)25 Feb 2026 · Company Update / General
Span Divergent Limited- Outcome of Board Meeting held on February 25, 202625 Feb 2026 · Others / Outcome without intimation
Span Divergent Limited - Preferential Issue of Equity Shares of the Company for consideration in cash21 Feb 2026 · Company Update / Preferential Issue
Span Divergent Limited - Preferential Issue of Equity Shares of the Company for Consideration in cash21 Feb 2026 · Company Update / Issue of Securities

Board meetings

5 Nov 2026 Board Meeting - Financial Results
11 Aug 2026 Board Meeting - Financial Results